191 related articles for article (PubMed ID: 34420239)
1. Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.
Genovese G; Maronese CA; Moltrasio C; Piccinno R; Marletta DA; De Luca G; Graziadei G; Granata F; Di Pierro E; Cappellini MD; Marzano AV
Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):141-149. PubMed ID: 34420239
[TBL] [Abstract][Full Text] [Related]
2. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
Delaby C; Lyoumi S; Ducamp S; Martin-Schmitt C; Gouya L; Deybach JC; Beaumont C; Puy H
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):45-52. PubMed ID: 19268001
[TBL] [Abstract][Full Text] [Related]
3. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
[TBL] [Abstract][Full Text] [Related]
4. Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up.
Heerfordt IM; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101928. PubMed ID: 32717453
[TBL] [Abstract][Full Text] [Related]
5. Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming.
Heerfordt IM; Heydenreich J; Philipsen PA; Lerche CM; Wulf HC
J Photochem Photobiol B; 2020 Dec; 213():112054. PubMed ID: 33075648
[TBL] [Abstract][Full Text] [Related]
6. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
Heerfordt IM; Fontenete S; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine for erythropoietic protoporphyria.
Heerfordt IM; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102793. PubMed ID: 35245673
[TBL] [Abstract][Full Text] [Related]
8. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
Holme SA; Worwood M; Anstey AV; Elder GH; Badminton MN
Blood; 2007 Dec; 110(12):4108-10. PubMed ID: 17804693
[TBL] [Abstract][Full Text] [Related]
9. Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria.
Heerfordt IM; Wulf HC
Br J Dermatol; 2016 Dec; 175(6):1284-1289. PubMed ID: 27603594
[TBL] [Abstract][Full Text] [Related]
10. Acquired erythropoietic protoporphyria: A systematic review of the literature.
Snast I; Kaftory R; Sherman S; Edel Y; Hodak E; Levi A; Lapidoth M
Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):29-33. PubMed ID: 31374130
[TBL] [Abstract][Full Text] [Related]
11. Phototesting in erythropoietic protoporphyria trials: A systematic review.
Heerfordt IM; Philipsen PA; Lerche CM; Wulf HC
Exp Dermatol; 2023 Jul; 32(7):1042-1047. PubMed ID: 37052136
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality.
Wulf HC; Nissen CV; Philipsen PA
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101582. PubMed ID: 31809913
[TBL] [Abstract][Full Text] [Related]
13. The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
Wang P; Sachar M; Lu J; Shehu AI; Zhu J; Chen J; Liu K; Anderson KE; Xie W; Gonzalez FJ; Klaassen CD; Ma X
Sci Adv; 2019 Sep; 5(9):eaaw6127. PubMed ID: 31555729
[TBL] [Abstract][Full Text] [Related]
14. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
[TBL] [Abstract][Full Text] [Related]
15. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic protoporphyria and early onset of cholestasis.
Khalili MJ; Farahmand F; Hirbod-Mobarakeh A; Yousefi A; Sotoudeh S; Monajemzadeh M; Razaghian A; Rezaei N
Turk J Pediatr; 2012; 54(6):645-50. PubMed ID: 23692792
[TBL] [Abstract][Full Text] [Related]
17. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
Halloy F; Iyer PS; Ghidini A; Lysenko V; Barman-Aksözen J; Grubenmann CP; Jucker J; Wildner-Verhey van Wijk N; Ruepp MD; Minder EI; Minder AE; Schneider-Yin X; Theocharides APA; Schümperli D; Hall J
Cell Chem Biol; 2021 Aug; 28(8):1221-1234.e6. PubMed ID: 33756123
[TBL] [Abstract][Full Text] [Related]
19. An explorative study of non-invasive ultra-weak photon emission and the anti-oxidative influence of oral zinc sulphate in light-sensitive patients with erythropoietic protoporphyria.
Petersen AB; Philipsen PA; Wulf HC
Skin Res Technol; 2012 Nov; 18(4):405-12. PubMed ID: 22092997
[TBL] [Abstract][Full Text] [Related]
20. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
